News Archives

News

CORONAVIRUS DISEASE 2019 AND THE PD COMMUNITY

Posted on March 20, 2020April 1, 2020 by Phil Franchina

APDA COVID-19 INFORMATION & RESOURCES: The American Parkinson Disease Association (APDA) is closely monitoring the Coronavirus Disease 2019 (also known as COVID-19) situation. As the disease can pose an increased threat for people with underlying health issues and/or advanced age, which includes many people living with Parkinson’s disease (PD), APDA is ever mindful of […]

The 26th Annual Parkinson’s Unity Walk

Posted on January 13, 2020January 13, 2020 by Phil Franchina

The American Parkinson Disease Association (APDA) is a proud partner of the 26th Annual Parkinson’s Unity Walk taking place on Saturday, April 25, 2020 in Central Park, New York City. 100% of donations raised by the event will go to research funded by the leading PD foundations, including APDA. In addition to raising awareness and funds […]

The FDA approves F-Dopa PET imaging to aid in early diagnosis of Parkinson’s disease

Posted on January 8, 2020January 8, 2020 by Dr. Rebecca Gilbert

The FDA approves F-Dopa PET imaging to aid in early diagnosis of Parkinson’s disease The FDA recently approved Flourodopa F18 (F-Dopa), a radioactive tracer for positron emission tomography (PET) that can help visualize the nerve endings of dopaminergic neurons. It can be used to help in the diagnosis of Parkinson’s disease (PD) and other parkinsonian […]

Deep brain stimulation and swimming

Posted on December 4, 2019December 4, 2019 by Phil Franchina

Deep brain stimulation and swimming Deep brain stimulation (DBS) is a surgical treatment for Parkinson’s disease (PD) symptoms in which small wires are inserted deep into the brain to deliver electrical current that allows for maintenance of more normal movement. DBS is particularly helpful for those with medication-resistant tremors as well as for those who […]

Promising results from the University of Pittsburgh APDA Center for Advanced Research

Posted on October 24, 2019December 12, 2019 by Phil Franchina

Promising results from the University of Pittsburgh APDA Center for Advanced Research Building off of pivotal APDA-funded work highlighted here, Dr. J. Timothy Greenamyre and his team, published a new study investigating the role of Leucine-rich Repeat Kinase (LRRK2) in the development of Parkinson’s disease (PD). LRRK2 is known to be mutated in a small […]

Taking Parkinson’s education to the farmers market: educating under-served communities

Posted on September 16, 2019September 16, 2019 by Phil Franchina

Taking Parkinson’s education to the farmers market: educating under-served communities Dr. Lynda Nwabuobi, Movement Disorder Fellow at Columbia Presbyterian Medical Center in New York City, attended APDA’s Diversity in Parkinson’s Disease (PD) Research Conference in May and was inspired. Dr. Nwabuobi had just spent the day learning about health care disparities in PD care, low […]

New medication, Istradefylline, gets approved for Parkinson’s disease

Posted on September 4, 2019 by Stephanie Paul

New medication, Istradefylline, gets approved for Parkinson’s disease On August 27, 2019, pharmaceutical company Kyowa Kirin received FDA approval for Istradefylline, a new medication for Parkinson’s disease (PD) to be used as an add-on treatment to carbidopa/levodopa for those experiencing OFF episodes. (For more information on OFF periods in PD, please see this recent APDA […]

APDA Seed Funding Leads to Prestigious NIH Research Grant

Posted on August 16, 2019August 16, 2019 by Stephanie Paul

APDA Seed Funding Leads to Prestigious NIH Research Grant

APDA is exceptionally proud to congratulate Dr. Beom-Chan Lee, APDA Research Grant awardee on receiving a recently-awarded National Institutes of Health (NIH) R21 grant.